-
- 1800 2010
- EN
Gentis news
Array
(
[0] => stdClass Object
(
[id] => 1317
[id_crawler] =>
[category_product] => NULL
[thumbnail] => 502585524_1119643676865800_2310105009568831395_n.jpg
[album] =>
[url_video] =>
[is_status] => 1
[is_featured] => 0
[is_form] => 1
[displayed_time] => 2025-06-06
[program] => 0
[number] => 1
[viewed] => 0
[type] =>
[type_career] =>
[level] =>
[address] =>
[address_career] =>
[expiration_time] => 0000-00-00
[created_time] => 2025-06-02 10:30:19
[updated_time] => 2025-09-08 15:10:13
[files] =>
[salary] =>
[time] =>
[created_by] => 63
[is_table_content] => 1
[language_code] => en
[slug] => GENTIS-launches-advances-obstetrics-and-pediatrics-genetic-testing-methods-at-the-2nd-expanded-nghe-an-obstetrics-and-pediatrics-scientific-conference-2025
[title] => GENTIS Launches Advanced Obstetrics and Pediatrics Genetic Testing Methods at the 2nd Expanded Nghe An Obstetrics and Pediatrics Scientific Conference 2025
[description] => On May 30–31, GENTIS was honored to accompany the 2nd Expanded Nghe An Obstetrics and Pediatrics Scientific Conference 2025 as a sponsor. In addition to offering engaging activities and attractive gifts at its exhibition booth, GENTIS also showcased its most advanced genetic testing solutions in the field of Obstetrics and Pediatrics. The eye-catching GENTIS booth attracted significant interest from many delegates who stopped by to explore and engage with the team.
[content] => 
At this year’s Obstetrics and Pediatrics event, GENTIS introduced a wide range of advanced genetic testing methods to the conference, including GEN9, 77 IEMs, biotinidase deficiency screening (SLSS), and notably, three new PGT packages: PGT-M for over 100 rare diseases, PGT NEXT, and PGT UPGRADE.
One of the standout features of the PGT-M 100+ test at GENTIS is its ability to detect more than 100 monogenic (single-gene) inherited disorders with high accuracy. By applying next-generation sequencing (NGS) technology in combination with family-specific marker design, PGT-M 100+ can precisely identify even the smallest DNA variants—factors that could potentially lead to disease. This allows the identification of embryos free of disease-causing genes, increasing the chances of a healthy baby. In addition to cutting-edge technology, the PGT-M service at GENTIS is supported by a team of experienced genetic counselors who provide comprehensive guidance before, during, and after testing.
PGT NEXT is a preimplantation genetic screening method that detects aneuploidy across all 24 chromosomes and identifies chromosomal segmental gains or losses. It can also detect embryos with polyploidy or monoploidy—conditions often excluded due to suspected fertilization abnormalities (such as 0PN, 1PN, 2.1PN, 3PN). By analyzing the entire genome with NGS and SNP genotyping, PGT NEXT increases the accuracy of chromosomal abnormality detection and ensures correct kinship identification among embryos in the same batch, thereby minimizing the risk of sample mix-ups due to handling errors.
PGT UPGRADE is an advanced version of preimplantation genetic testing, capable of detecting aneuploidy across all 24 chromosomes and identifying segmental chromosomal abnormalities larger than 5 Mb. Notably, this test can also detect balanced translocations—genetic abnormalities that may be inherited from either parent, which do not necessarily manifest as disease but can affect reproductive health in future generations. PGT UPGRADE provides in-depth genetic information, helping to optimize embryo selection and increasing the chances of successful pregnancy and healthy offspring.
GEN9 is a pre-marital or pre-pregnancy genetic screening test that detects 9 autosomal recessive genetic disorders, including: Alpha-Thalassemia, Beta-Thalassemia, G6PD deficiency, Phenylketonuria, Galactose metabolism disorder, Citrin deficiency-related jaundice, Pompe disease, Wilson disease, 5-alpha reductase deficiency type 2, and Fabry disease. GEN9 evaluates the risk of parents passing on genetic disorders to their children and provides reproductive support to eliminate disease-causing genes.
The 77 IEMs and SLSS biotinidase deficiency tests are two critical newborn screening methods performed shortly after birth to detect congenital disorders early. The 77 IEMs test identifies over 70 different metabolic disorders, including amino acid, fatty acid, and organic acid metabolism disorders. Meanwhile, the SLSS test detects biotinidase deficiency, a vital enzyme in biotin metabolism. Both tests play an essential role in identifying conditions that may not present obvious symptoms initially. Early diagnosis allows timely medical intervention, reducing the risk of severe complications and improving newborn health outcomes.
The GENTIS exhibition booth attracted significant attention from delegates and attendees. At the booth, doctors’ questions regarding GENTIS genetic testing services were thoroughly and clearly addressed. Notably, healthcare professionals expressed high appreciation for GENTIS’s genetic testing solutions in the field of obstetrics and pediatrics.
Through this event, GENTIS hopes to continue partnering with doctors, specialists, hospitals, and clinics on the journey to make accurate, timely genetic testing more accessible to Vietnamese people. With a mission to contribute to improving the physical and intellectual well-being of the Vietnamese population, GENTIS is committed to continuously updating, researching, and developing genetic testing services to enhance the quality of screening and healthcare in the community.
[content_more] =>
[meta_title] =>
[meta_description] => On May 30–31, GENTIS was honored to accompany the 2nd Expanded Nghe An Obstetrics and Pediatrics Scientific Conference 2025 as a sponsor.
[meta_keyword] => GENTIS
[thumbnail_alt] =>
[post_id] => 1317
[category_id] => 14
)
[1] => stdClass Object
(
[id] => 1315
[id_crawler] =>
[category_product] => NULL
[thumbnail] => 600x400-web_-_copy.jpg
[album] =>
[url_video] =>
[is_status] => 1
[is_featured] => 0
[is_form] => 1
[displayed_time] => 2025-05-29
[program] => 0
[number] => 1
[viewed] => 0
[type] =>
[type_career] =>
[level] =>
[address] =>
[address_career] =>
[expiration_time] => 0000-00-00
[created_time] => 2025-05-29 09:31:35
[updated_time] => 2025-09-08 15:09:55
[files] =>
[salary] =>
[time] =>
[created_by] => 63
[is_table_content] => 1
[language_code] => en
[slug] => Children's-day-june-1st-GENTIS-sends-love-through-adorable-teddy-bears
[title] => Children’s Day June 1st - GENTIS Sends Love Through Adorable Teddy Bears
[description] => International Children’s Day on June 1st is not only an occasion for children to have fun and receive meaningful gifts, but also a chance for GENTIS to accompany parents on their journey of love and protection for their children from the very first days of life.
[content] => 
On the occasion of International Children’s Day on June 1st, GENTIS is pleased to offer adorable teddy bears as gifts to couples who register for Newborn Screening (SLSS) tests at the following hospital locations:
-
Thanh Nhàn Hospital
-
Lang Son Hospital
-
Dien Bien Hospital
-
Bac Giang Obstetrics and Pediatrics Hospital
-
Vinh Phuc Obstetrics and Pediatrics Hospital
-
Luc Ngan Health Center
These cute teddy bears will be a heartfelt gift from GENTIS to the babies who are soon to be born.
Newborn screening is a vital test to detect early genetic disorders such as congenital hypothyroidism, G6PD deficiency, congenital adrenal hyperplasia, and more. Early detection and timely treatment will help your child grow up healthy and develop like any other child.
With an ISO-certified testing process, advanced technology, and a team of highly skilled specialists, GENTIS is proud to be a pioneer in genetic testing, always prioritizing safety, accuracy, and dedication.
Program Duration: From June 1, 2025, to June 30, 2025.
Gift quantities are limited, and the program may end early if all gifts are distributed.
Let this small gift from GENTIS convey our best wishes for your baby’s strong and complete start in life!
[content_more] => [meta_title] => Children’s Day June 1st - GENTIS Sends Love Through Adorable Teddy Bears [meta_description] => International Children’s Day on June 1st is not only an occasion for children to have fun and receive meaningful gifts, but also a chance for GENTIS to accompany parents on their journey of love and protection for their children from the very first days o [meta_keyword] => GENTIS [thumbnail_alt] => [post_id] => 1315 [category_id] => 14 ) [2] => stdClass Object ( [id] => 1311 [id_crawler] => [category_product] => NULL [thumbnail] => 3-min_-_copy.jpg [album] => [url_video] => [is_status] => 1 [is_featured] => 0 [is_form] => 1 [displayed_time] => 2025-05-23 [program] => 0 [number] => 1 [viewed] => 0 [type] => [type_career] => [level] => [address] => [address_career] => [expiration_time] => 0000-00-00 [created_time] => 2025-05-23 15:38:17 [updated_time] => 2025-09-05 15:53:02 [files] => [salary] => [time] => [created_by] => 63 [is_table_content] => 1 [language_code] => en [slug] => GENTIS-demonstrates-its-commitmet-to-community-responsibility-through-the-journey-of-a-french-director-searching-for-his-birth-mother-in-Vietnam [title] => GENTIS demonstrates its commitment to community responsibility through the journey of a french director searching for his birth mother in Vietnam [description] => On May 21, 2025, a heartwarming story came to a close with an emotional reunion hug after 31 years of separation: French-Vietnamese filmmaker Arthur Chareire found his biological mother, Ms. Nguyễn Thị Hợi, in Vietnam. This miraculous journey was not only the result of Arthur's determination to reconnect with his roots, but also thanks to a silent yet pivotal factor: the support of GENTIS — a pioneer in genetics that facilitated the DNA testing between Arthur and his mother. GENTIS’s involvement in this journey is a clear testament to the company’s commitment to community responsibility — one of the core values it has always upheld and pursued. [content] =>A Journey Spanning Over Three Decades and the Longing to Say “Mom”
Arthur Chareire was born in 1994 at Bạch Mai Hospital in Hanoi. Just a few days after birth, the baby named Vũ Văn Dậu — Arthur’s birth name — was adopted by a French family. Though raised in a loving home, Arthur always felt an unfillable void: the absence of the woman who gave birth to him in Vietnam. Driven by a deep yearning to return to his origins, Arthur began a sacred quest to find his biological mother. He shared his personal information, birth certificate, and photos on social media in the hopes of finding a clue.
His post quickly went viral and eventually reached Ms. Nguyễn Thị Hợi — a woman who had given birth around the same time at Bạch Mai Hospital. After multiple conversations and verification of the details, the two decided to proceed with a DNA test to confirm their biological relationship. This was the moment when GENTIS joined the filmmaker in his sacred journey.
GENTIS — A DNA Testing Organization That Puts People First
Colonel Hà Quốc Khanh, former Deputy Director of the Institute of Criminal Science under the Ministry of Public Security and Senior Advisor at GENTIS, announced the DNA test results.
With nearly 15 years of experience in genetic testing, GENTIS is recognized as one of Vietnam’s most trusted institutions for paternity, genetic, and prenatal screenings. However, for GENTIS, testing is more than a scientific service — it is a means to serve higher values: truth, family, and justice. Understanding the emotional significance of this journey, GENTIS proactively covered all testing costs for Arthur and Ms. Hợi — a gesture that clearly reflects the company’s commitment to the community and to those in need of reconnection, guided by compassion rather than limited by finances.
The DNA testing process was carried out by GENTIS with absolute accuracy and in strict adherence to international standards. The GENTIS team analyzed and compared Arthur and Ms. Hợi’s DNA samples in a modern, transparent laboratory setting. Just a few days later, the result was revealed: they are indeed mother and son.
More Than a Test — A Mission
Ms. Nguyễn Thị Hợi, biological mother of French director Arthur Chareire, provides her DNA sample at GENTIS.
Arthur and his mother’s story is not unique. Every year in Vietnam, thousands of people long to reunite with their birth parents, and countless parents hold onto hope of seeing a lost child again. In these emotional and often challenging journeys, GENTIS plays a role beyond just providing DNA testing services — it becomes a bridge of humanity, supporting compassion and reunion.
For GENTIS, community responsibility goes beyond accurate results — it’s reflected in meaningful actions such as offering free or discounted services for those in difficult circumstances and sharing scientific knowledge transparently and accessibly. With dedication and empathy, GENTIS believes that every DNA sample is not just a string of genetic code, but a chance to heal lives, reignite hope, and continue writing stories of heartfelt reunions.
The Journey Is Not Over — A Future of Reconnection
Arthur is expected to return to Vietnam in November 2025 to meet his mother in person, following their first reunion via video call. He shared, “I don’t blame my mother. On the contrary, I am grateful that she gave me life. Thank you, GENTIS, for giving me the certainty to call someone ‘Mom’ again without doubt.”
Arthur’s story is a powerful example of how technology, guided by compassion, can create profound meaning. And GENTIS is proud to walk alongside these sacred moments, serving as a bridge for millions of hearts searching for each other across life’s many crossroads.
[content_more] => [meta_title] => GENTIS demonstrates its commitment to community responsibility through the journey of a french direc [meta_description] => On May 21, 2025, a heartwarming story came to a close with an emotional reunion hug after 31 years of separation: French-Vietnamese filmmaker Arthur Chareire found his biological mother, Ms. Nguyễn Thị Hợi, in Vietnam. [meta_keyword] => GENTIS,ADN [thumbnail_alt] => [post_id] => 1311 [category_id] => 14 ) [3] => stdClass Object ( [id] => 1310 [id_crawler] => [category_product] => NULL [thumbnail] => hội-nghị-khoa-học-chuyen-nganh-sản---nhi-nghệ-an.jpg [album] => [url_video] => [is_status] => 1 [is_featured] => 0 [is_form] => 1 [displayed_time] => 2025-05-22 [program] => 0 [number] => 1 [viewed] => 0 [type] => [type_career] => [level] => [address] => [address_career] => [expiration_time] => 0000-00-00 [created_time] => 2025-05-22 14:46:04 [updated_time] => 2025-09-08 15:11:43 [files] => [salary] => [time] => [created_by] => 63 [is_table_content] => 1 [language_code] => en [slug] => GENTIS-accompanies-the-2nd-expanded-obstetrics-and-pediatrics-scientific-conference-of-Nghe-An-in-2025 [title] => GENTIS Accompanies the 2nd Expanded Obstetrics and Pediatrics Scientific Conference of Nghe An in 2025 [description] => The 2nd Expanded Obstetrics and Pediatrics Scientific Conference of Nghe An in 2025 is a significant scientific event in the field of reproductive health, organized by the Nghe An Obstetrics and Pediatrics Hospital. This is not only an important event for medical professionals but also a memorable milestone marking the 40-year development journey of Nghe An Obstetrics and Pediatrics Hospital (June 1, 1985 – June 1, 2025). It is a valuable opportunity for learning and also an occasion for GENTIS to demonstrate its commitment to the sustainable development of Vietnam’s healthcare sector. [content] =>This year’s conference will take place on Friday and Saturday, May 30–31, 2025, at Giao Te Hotel – No. 9 Ho Tung Mau Street, Hung Binh Ward, Vinh City, Nghe An Province.
As a sponsor accompanying this conference, GENTIS is honored to contribute in a small but meaningful way to this important event. The GENTIS booth at the event will showcase advanced testing methods in obstetrics and pediatrics, particularly highlighting three new PGT (Preimplantation Genetic Testing) packages: PGT-M 100+ for rare diseases, PGT NEXT, and PGT UPGRADE.
One outstanding feature of the PGT-M 100+ test at GENTIS is its ability to detect over 100 single-gene disorders with high accuracy. By using next-generation sequencing (NGS) technology combined with family-specific marker design, PGT-M 100+ can precisely detect even minor DNA variations—hidden factors that can lead to disease. This method allows for the identification of embryos that are free from disease-causing genes, thereby increasing the chance of having a healthy baby. In addition to using advanced technology, GENTIS’s PGT-M service includes comprehensive support from a team of experienced genetic counselors, assisting clients before, during, and after testing.
PGT NEXT is a preimplantation genetic screening method that detects aneuploidies across all 24 chromosomes and identifies structural abnormalities such as chromosomal deletions and duplications. This test can also detect embryos with polyploidy or haploidy—conditions often discarded due to suspected fertilization abnormalities (e.g., 0PN, 1PN, 2.1PN, 3PN). By analyzing the entire genome using NGS combined with SNP genotyping, PGT NEXT increases the accuracy of chromosomal abnormality detection and ensures the correct identification of genetic relationships among embryos within the same group, minimizing the risk of sample mix-ups due to human error.
PGT UPGRADE is an enhanced version of preimplantation genetic testing, capable of detecting not only aneuploidies across 24 chromosomes but also structural chromosomal abnormalities larger than 5 Mb. Notably, this test can identify embryos carrying balanced translocations—a genetic abnormality that may be inherited from a parent without showing symptoms but can impact the reproductive health of future generations. PGT UPGRADE provides in-depth and detailed genetic information, optimizing embryo selection before transfer, thereby improving the likelihood of successful pregnancy and healthy offspring.
In addition, GENTIS will also introduce three new tests at the Nghe An Obstetrics and Pediatrics Scientific Conference: GEN9, 77 Inherited Metabolic Disorders (77IMDs), and SLSS Biotinidase Deficiency Screening.
GEN9 is a pre-marital/pre-pregnancy genetic screening test that screens for 9 recessive single-gene disorders such as Alpha-thalassemia, Beta-thalassemia, G6PD deficiency, phenylketonuria, galactose metabolism disorder, citrin deficiency-related cholestatic jaundice, Pompe disease, Wilson disease, 5-alpha-reductase type 2 deficiency, and Fabry disease. GEN9 helps assess the risk of passing genetic conditions to offspring if both parents are carriers, allowing for timely reproductive planning and support to eliminate disease-causing genes.
The 77IMDs test and SLSS Biotinidase Deficiency Screening are two essential newborn screening methods to detect congenital disorders early. The 77IMDs test screens for over 70 metabolic disorders, including issues with amino acid, fatty acid, and organic acid metabolism. Meanwhile, SLSS Biotinidase Deficiency Screening detects a deficiency in the biotinidase enzyme, crucial for biotin metabolism. These tests are vital in identifying conditions that may not present symptoms at birth. Early diagnosis allows for timely medical intervention, reducing the risk of severe complications and improving the quality of life for newborns.
Let’s welcome the 2nd Expanded Obstetrics and Pediatrics Scientific Conference of Nghe An, a significant event marking progress and success in Vietnam’s healthcare sector!
We look forward to welcoming distinguished delegates at the GENTIS booth!
This year’s conference will take place on Friday, April 18, 2025, at the Pan Pacific Hotel Hanoi (1 Thanh Nien Road, Ba Dinh, Hanoi).
We are honored to accompany the conference as a sponsor. GENTIS’ booth will offer many exciting activities and attractive gifts for delegates. Additionally, the GENTIS booth will focus on presenting solutions for genetic screening and diagnosis in the field of reproductive support, particularly the three new PGT testing packages: PGT +100 rare diseases, PGT NEXT, and PGT UPGRADE.
One of the key advantages of PGT-M testing at GENTIS is the ability to analyze over 100 single-gene genetic diseases with high accuracy, allowing for the detection of even small DNA variants that may cause disease. By applying next-generation sequencing (NGS) technology combined with family-specific marker design, PGT-M ensures accuracy in identifying healthy embryos, thus increasing the chances of having a child free from genetic disorders. In addition to advanced technology, PGT-M for 100+ rare diseases also includes support from a dedicated genetic counseling team, accompanying patients before, during, and after testing.
PGT NEXT is a pre-embryo transfer genetic test capable of detecting aneuploidy on 24 chromosomes, additional abnormalities, and chromosomal deletions. It can also detect embryos with triploidy or monosomy. This helps avoid transferring embryos with these abnormalities, while also preventing wasting euploid embryos that have fertilization issues (0PN, 1PN, and 2.1/3PN). Additionally, PGT NEXT provides genetic information for embryo selection prior to transfer.
The combination of whole-genome sequencing (NGS) with SNP analysis enhances the resolution of genetic screening to detect aneuploidy. This method allows for the detection of monosomic and trisomic chromosomes, increasing the number of euploid embryos available for transfer by identifying truly diploid embryos among abnormal fertilized embryos (0PN, 1PN, 2.1PN, 3PN). Furthermore, SNP analysis ensures accurate identification of whether an embryo shares a genetic relationship with other embryos in the same group, reducing the risk of sample mix-ups due to procedural errors.
PGT UPGRADE is a pre-embryo transfer genetic test capable of detecting aneuploidy on 24 chromosomes, additional abnormalities, chromosomal deletions larger than 5 Mb, and particularly the ability to detect balanced translocations inherited from parents. Additionally, PGT UPGRADE provides genetic information for embryo selection before transfer.
At the conference, Dr. Pham Dinh Minh (Director of R&D at GENTIS) will present a report titled: "Factors Affecting the Outcome of Mosaic Embryos from a Genetic Lab Perspective."
We cordially invite doctors, embryologists, and experts to visit the GENTIS booth to update themselves on the most modern and advanced pre-implantation genetic screening solutions, serving the healthcare needs of the Vietnamese people.
[content_more] => [meta_title] => GENTIS accompanies the ART ADVANCED 12 Conference: “New perspectives on reproductive science: from c [meta_description] => The ART ADVANCED 12 conference is a significant scientific event in the field of reproductive support organized by the Hanoi Reproductive Support Association. [meta_keyword] => GENTIS,Conference [thumbnail_alt] => [post_id] => 1300 [category_id] => 14 ) [5] => stdClass Object ( [id] => 1299 [id_crawler] => [category_product] => NULL [thumbnail] => ảnh-5913.jpg [album] => [url_video] => [is_status] => 1 [is_featured] => 0 [is_form] => 0 [displayed_time] => 2025-04-09 [program] => 0 [number] => 1 [viewed] => 0 [type] => [type_career] => [level] => [address] => [address_career] => [expiration_time] => 0000-00-00 [created_time] => 2025-04-09 09:11:03 [updated_time] => 2025-09-08 15:13:32 [files] => [salary] => [time] => [created_by] => 63 [is_table_content] => 1 [language_code] => en [slug] => Gentis-honored-at-the-vietnam's-number-1-brand-2025-announcement-ceremony [title] => GENTIS honored at the Vietnam's Number 1 Brand 2025 announcement ceremony [description] => At the Vietnam’s Number 1 Brand 2025 announcement ceremony organized by the Asian Business Development Research Center, Genetic Analysis Services Joint Stock Company (GENTIS) was honored with the “Vietnam’s Number 1 Brand 2025” award in the genetic analysis field - Gold category, as well as the “Best Medical Product/Service for Consumers in 2025” award for the PGT-Max 1 test. [content] =>GENTIS Confirms its Position with the Vietnam’s Number 1 Brand 2025 Award in Genetic Analysis - Gold Category
The Vietnam’s Number 1 Brand announcement ceremony is an annual program organized by the Asian Business Development Research Center. The event aims to encourage and honor businesses and entrepreneurs who have continuously strived, overcome market challenges, and made positive contributions to the community, thereby fostering the country’s economy in the new era - the Era of National Growth.
The awards are selected based on international quality standards for businesses with high-quality products and services. To be recognized for the award, products must meet strict criteria, including: being a leading brand in the industry; having products and services widely recognized by consumers; demonstrating sustainable development strategies; contributing to the economy; complying with environmental, tax, customs, intellectual property, and labor regulations; and demonstrating social and community responsibility.
In addition, depending on the industry sector, the selection committee will evaluate specific criteria: capabilities; management philosophy; technology and innovation activities; financial capacity; human resources; marketing strategies, etc. GENTIS excellently met these criteria and proudly received the Gold category “Vietnam’s Number 1 Brand 2025” award in the Genetic Analysis field.
Mr. Pham Dinh Minh (R&D Director of GENTIS) Receives the Gold Cup and Certificate for Vietnam’s Number 1 Brand 2025 in Genetic Analysis
This award is a testament to the quality of GENTIS’s tests on the market and the trust and loyalty of its customers towards the GENTIS brand. It also serves as motivation for the company to continue delivering even more value to its partners and customers.
Looking at its development journey, it is evident that GENTIS has always been at the forefront of making new advancements in applying technology and building a comprehensive genetic testing ecosystem that caters to a wide range of customers. GENTIS’s product and service ecosystem continues to expand and diversify, including services for assisted reproduction, obstetrics and gynecology, andrology, hematology - immunology, oncology - pediatrics, and family testing.
Furthermore, to increase partner and customer satisfaction, GENTIS consistently focuses on improving and optimizing the testing process to save costs for patients. GENTIS also strengthens training efforts to improve the professional skills, knowledge, and expertise of its staff to meet the increasing demands of the job.
GENTIS understands that customer satisfaction comes not only from good products and services but also from comprehensive, attentive care experiences. GENTIS will continue to strive to bring more value to the community.
GENTIS Awarded Vietnam’s Number 1 Brand 2025 in Genetic Analysis - Gold Category
PGT-Max 1 Test - A Technological Breakthrough in Pre-implantation Genetic Testing
At the Vietnam’s Number 1 Brand 2025 announcement ceremony, GENTIS’s PGT-Max 1 test was honored in the “Best Medical Product/Service for Consumers” category. This is a significant milestone for GENTIS in asserting the quality of the PGT-Max 1 test.
According to experts, genetic disorders in assisted reproduction are increasingly on the rise. One method to detect genetic abnormalities in embryos is Pre-implantation Genetic Testing for Aneuploidy (PGT-Max 1). PGT-Max 1 is a pre-implantation genetic test that helps select embryos without chromosomal abnormalities (24 chromosomes), without additional mutations, or chromosomal segment deletions, optimizing the embryo selection process before IVF (in vitro fertilization), ensuring that the child born is healthy and free of the genetic abnormalities detected.
GENTIS’s PGT-Max 1 Test Recognized as the Best Medical Product/Service for Consumers in 2025
GENTIS has successfully optimized and applied the PGT-Max 1 test on embryos for many infertile couples hoping for a child. Thanks to the PGT-Max 1 test, doctors and experts can select embryos with good genetic quality, increasing the chances of successful implantation during IVF, ensuring that the child is born healthy and free from the genetic abnormalities screened.
At GENTIS, the PGT-Max 1 test is performed using advanced technologies, including NGS sequencers from Illumina (USA) and specialized bioinformatics software, with the highest sensitivity and specificity of up to 99.9%. GENTIS will also continue to strive to develop and deliver the most advanced and safest genetic testing solutions as part of its mission to enhance the physical and intellectual well-being of the Vietnamese people.
The Vietnam’s Number 1 Brand 2025 award in Genetic Analysis and the Best Medical Product/Service for Consumers in 2025 for the PGT-Max 1 test marks a milestone acknowledging GENTIS’s contributions. This will serve as motivation for GENTIS to continue its mission to “enhance the intellect and health of the Vietnamese people” in the future.
[content_more] => [meta_title] => GENTIS honored at the Vietnam's Number 1 Brand 2025 announcement ceremony [meta_description] => At the Vietnam’s Number 1 Brand 2025 announcement ceremony organized by the Asian Business Development Research Center, Genetic Analysis Services Joint Stock Company (GENTIS) was honored with the “Vietnam’s Number 1 Brand 2025” award in the genetic analys [meta_keyword] => GENTIS,Awards,PGT MAX 1 [thumbnail_alt] => [post_id] => 1299 [category_id] => 14 ) [6] => stdClass Object ( [id] => 1298 [id_crawler] => [category_product] => NULL [thumbnail] => 3-min.jpg [album] => [url_video] => [is_status] => 1 [is_featured] => 0 [is_form] => 1 [displayed_time] => 2025-04-09 [program] => 0 [number] => 1 [viewed] => 0 [type] => [type_career] => [level] => [address] => [address_career] => [expiration_time] => 0000-00-00 [created_time] => 2025-04-09 08:21:08 [updated_time] => 2025-09-08 15:13:42 [files] => [salary] => [time] => [created_by] => 63 [is_table_content] => 1 [language_code] => en [slug] => Gentis-collaborates-with-the-department-of-andrology-and-sexology-hanoi-university-of-medicine-to-organize-a-scientific-seminar [title] => GENTIS collaborates with the Department of Andrology and Sexology - Hanoi University of Medicine to organize a scientific seminar [description] => Recently, GENTIS collaborated with the Department of Andrology and Sexology at Hanoi University of Medicine to successfully organize a scientific seminar aimed at helping doctors and healthcare staff gain a better understanding of two specialized test packages: Whole Exome Sequencing (WES) and Sperm DNA Fragmentation. [content] =>The seminar at Hanoi University of Medicine was attended by numerous experts and doctors from the Department of Andrology and Sexology, such as Associate Prof. Dr. Nguyen Hoai Bac (Head of the Department), MSc. Dr. Tran Van Kien, MSc. Dr. Do Ich Dinh, MSc. Dr. Chu Thi Chi, and MSc. Dr. Nguyen Cao Thang. From GENTIS, the seminar was attended by MSc. Hoang Thi Nhung (Head of R&D) and MSc. NT. Vu Thu Huong (R&D Specialist).
At the beginning of the seminar, MSc. NT. Vu Thu Huong explained that high levels of sperm DNA fragmentation are one of the causes of male infertility. There are many factors that lead to sperm fragmentation. According to MSc. NT. Vu Thu Huong, Sperm DNA testing is an essential method for evaluating the overall quality of a patient's sperm. This test helps quantify the percentage of sperm DNA fragmentation by detecting color changes in a dye through a flow cytometry system (which analyzes up to 10,000 sperm), helping identify the cause of infertility in cases where the semen analysis result is normal.
In addition, the sperm DNA fragmentation test can also explain repeated miscarriages, unexplained infertility, and failed IVF attempts. Therefore, evaluating sperm quality through sperm DNA fragmentation testing is extremely necessary, as it helps doctors predict fertility potential and determine the most suitable intervention for assisted reproduction.
At GENTIS, sperm DNA fragmentation (Sperm DNA) tests are conducted using the SCSA (Sperm Chromatin Structure Assay) method, ensuring high stability, accuracy, and performance.
A unique feature of this test is the clear categorization of sperm DNA fragmentation thresholds. This helps doctors better screen cases of unexplained infertility, thus guiding treatment intervention.
In addition to the Sperm DNA fragmentation test, the seminar also featured a discussion of new information about the Whole Exome Sequencing (WES) test. According to MSc. Hoang Thi Nhung (GENTIS), WES is a DNA sequencing method aimed at analyzing the entire protein-coding region, or Exons, in the human genome. GENTIS uses next-generation sequencing (NGS) technology on the NovaSep 6000 system to sequence the entire exon region of around 22,000 genes (covering over 85% of disease-causing mutations). This allows for the detection of point mutations, small deletions/inserts, and CNVs. Whole Exome Sequencing provides the ability to diagnose genetic diseases of unknown causes, particularly rare and complex diseases, and detect genetic variants associated with neurological, cardiovascular, and other conditions.
Through the discussion, doctors from the Department of Andrology and Sexology at Hanoi University of Medicine highly appreciated the significant improvements in WES and Sperm DNA testing and posed many in-depth questions regarding these two tests. This demonstrates the interest of medical professionals in GENTIS’s WES and Sperm DNA tests. We hope that after this scientific seminar, GENTIS will continue to have the opportunity to collaborate and work with Hanoi University of Medicine in the future!
[content_more] => [meta_title] => GENTIS collaborates with the Department of Andrology and Sexology - Hanoi University of Medicine to [meta_description] => Recently, GENTIS collaborated with the Department of Andrology and Sexology at Hanoi University of Medicine to successfully organize a scientific seminar aimed at helping doctors and healthcare staff gain a better understanding of two specialized test pac [meta_keyword] => GENTIS,SPERM DNA,WES [thumbnail_alt] => [post_id] => 1298 [category_id] => 14 ) [7] => stdClass Object ( [id] => 1295 [id_crawler] => [category_product] => NULL [thumbnail] => 487932123_1057582843073573_1848132115822519272_n.jpg [album] => [url_video] => [is_status] => 1 [is_featured] => 0 [is_form] => 0 [displayed_time] => 2025-04-01 [program] => 0 [number] => 1 [viewed] => 0 [type] => [type_career] => [level] => [address] => [address_career] => [expiration_time] => 0000-00-00 [created_time] => 2025-04-01 08:49:27 [updated_time] => 2025-09-08 15:13:58 [files] => [salary] => [time] => [created_by] => 63 [is_table_content] => 1 [language_code] => en [slug] => Happy-motherhood-journey-prenatal-class-equipping-expectant-mothers-with-useful-knowledge [title] => "Happy Motherhood Journey" Prenatal Class - Equipping Expectant Mothers with Useful Knowledge [description] => Recently, the 5th-floor hall of Hanoi Andrology and Fertility Hospital collaborated with the Happy Home AF HANOI Association successfully chaired the “Happy Motherhood Journey” prenatal class. GENTIS was honored to accompany the event as a sponsor. [content] =>The class attracted participation of more than expectant mothers, bringing a professional and warm ambience filled with valuable insights. The prenatal class featured MSc. Dr. Hoang Van Khanh and specialist doctor level 1 Luu Ba Hung - specialists in Obstetrics and Gynecology at the Hanoi Andrology and Fertility Hospital.
With years of experiences and an amiable sharing style, the two doctors had provided useful answers related to common issues faced during pregnancy. This helped the mothers have better preparations physically and mentally for the journey of pregnancy and childbirth.
During the interactive Q&A section, a lot of practical questions were asked covering topics such as signs of preterm labor, recognizing labor contractions, and concerns regarding nutritions. The doctors not only answered the questions thoughtfully, but also shared real-life stories from their experiences treating expectant mothers, helping them better understand the challenging but joyful journey of motherhood.
The class concluded in a warm and emotional atmosphere. Not only the expectant mothers gained invaluable knowledge, but also they received meaningful gifts from the organizers as a loving reminder of the sacred journey of parenthood.
In the future, GENTIS, in partnership with the hospital, will continue to organize more prenatal classes to accompany families in preparing a solid foundation for the arrival of their beloved babies.
[content_more] => [meta_title] => "Happy Motherhood Journey" Prenatal Class - Equipping Expectant Mothers with Useful Knowledge [meta_description] => Recently, the 5th-floor hall of Hanoi Andrology and Fertility Hospital collaborated with the Happy Home AF HANOI Association successfully chaired the “Happy Motherhood Journey” prenatal class. GENTIS was honored to accompany the event as a sponsor. [meta_keyword] => GENTIS,Prenatal class,Expectant mothers [thumbnail_alt] => [post_id] => 1295 [category_id] => 14 ) )
GENTIS Launches Advanced Obstetrics and Pediatrics Genetic Testing Methods at the 2nd Expanded Nghe An Obstetrics and Pediatrics Scientific Conference 2025
Children’s Day June 1st - GENTIS Sends Love Through Adorable Teddy Bears
GENTIS demonstrates its commitment to community responsibility through the journey of a french director searching for his birth mother in Vietnam
GENTIS Accompanies the 2nd Expanded Obstetrics and Pediatrics Scientific Conference of Nghe An in 2025
GENTIS accompanies the ART ADVANCED 12 Conference: “New perspectives on reproductive science: from clinical data to personalized treatment”
GENTIS honored at the Vietnam's Number 1 Brand 2025 announcement ceremony
GENTIS collaborates with the Department of Andrology and Sexology - Hanoi University of Medicine to organize a scientific seminar
"Happy Motherhood Journey" Prenatal Class - Equipping Expectant Mothers with Useful Knowledge
Please fill in the information below to receive our supports and consultations!
Please fill in the information below to receive our supports and consultations!
